Latest News
Breast Cancer Awareness 2025: Access and Awareness Saves Lives
Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with...
How AI Could Bridge Gaps Between Physicians and Patients with Intellectual and Developmental Disabilities
Insights from research and an interview with Dr. Dimitri Christakis, MD, MPH, chief health officer at Special Olympics International, and professor of paediatrics at the University of Washington, as featured in a recent JAMA interview. Artificial intelligence (AI) is...
Pharmalys Founder and CEO Marieme Ba at PCMG25: The Future of Clinical Trials in Africa
In June 2025, Marieme Ba, Founder and CEO of Pharmalys, took the stage at the PCMG25 Annual Assembly in Málaga, joining fellow panellists Pierre Brichot (MCT-CRO), Jacqueline Mirera (CREA-N), and Chris Obwanga (IQVIA), in a session chaired by Sandra Johnson. Their...
A Breakthrough in Malaria Care for the Youngest Patients
It’s a sobering truth: malaria still claims the lives of hundreds of thousands of children every year, with the youngest being most at risk. Until now, doctors treating newborns and very small infants under 5 kg faced a dilemma - no treatment had ever been designed...
Pharmacoequity: Improving Representation in Medicine and Fairness in Care
Access to safe and effective medicines is a cornerstone of modern healthcare. Yet, not everyone enjoys equal benefit from the advancements in pharmaceutical research and innovation. Pharmacoequity is the principle that every individual, regardless of race, ethnicity,...
The Microbiome and Cancer: What Do We Know?
Insights from research and an interview with Dr Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, as featured in a recent JAMA interview. The human body is home to trillions of microbes - bacteria, viruses, fungi, and other microorganisms - that...
Pharmalys at the Mastercard Foundation Networking Event for Employers and Associates
On 26 June 2025, the Mastercard Foundation held a networking event for employers and associates at Noom Hotel in Dakar, Senegal. The event marked the end of the programme’s final evaluation phase and brought together associates, line managers, and stakeholders to...
A spotlight on the Pharmalys Regulatory Affairs Unit
As clinical research expands rapidly across the African continent, the demand for strategic and locally grounded regulatory support is becoming more critical than ever. From clinical trial start-up to post-marketing activities, effective regulatory oversight is key to...
Pharmalys at the EDCTP Forum, Kigali 2025
Pharmalys participated as an exhibitor at the EDCTP Forum 2025, held from 15 to 20 June 2025 in Kigali, Rwanda. The event brought together a diverse community of stakeholders, providing a unique platform for collaboration, learning, and visibility. This year’s theme,...
July 2025 Newsletter: Female Genital Mutilation, Project Management Training, Pharmalys Regulatory Affairs and Study Start-Up Services
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical...